Victoza$526
Byetta$816
Wegovy$871
Trulicity$975
Ozempic$992
Rybelsus$995
Zepbound$1,052
Mounjaro$1,077
Saxenda$1,308
Victoza$526
Byetta$816
Wegovy$871
Trulicity$975
Ozempic$992
Rybelsus$995
Zepbound$1,052
Mounjaro$1,077
Saxenda$1,308
glp1foryou
Check the register

BSP Pharmaceuticals SpA

BSP Pharmaceuticals SpA lists 12 GLP-1 packages in the FDA NDC directory, covering tirzepatide.

By Sam Reed · Founder and data lead

BSP Pharmaceuticals SpA appears on 12 GLP-1 packages in the FDA National Drug Code directory, covering tirzepatide. The labeler is the firm whose name is on the package. It is not necessarily the manufacturer, and it is never the telehealth programme that sells you the prescription.

The listing

Every package it lists

ProductIngredientFormPackageCategory
—Multiple-Dose Tirzepatide InjectionINJECTION, SOLUTION168 VIAL in 1 TRAY (43624-033-01) / .6 mL in 1 VIALDRUG FOR FURTHER PROCESSING
—Multiple-Dose Tirzepatide InjectionINJECTION, SOLUTION168 VIAL in 1 TRAY (43624-034-01) / .6 mL in 1 VIALDRUG FOR FURTHER PROCESSING
—Multiple-Dose Tirzepatide InjectionINJECTION, SOLUTION168 VIAL in 1 TRAY (43624-035-01) / .6 mL in 1 VIALDRUG FOR FURTHER PROCESSING
—Multiple-Dose Tirzepatide InjectionINJECTION, SOLUTION168 VIAL in 1 TRAY (43624-036-01) / .6 mL in 1 VIALDRUG FOR FURTHER PROCESSING
—Multiple-Dose Tirzepatide InjectionINJECTION, SOLUTION168 VIAL in 1 TRAY (43624-037-01) / .6 mL in 1 VIALDRUG FOR FURTHER PROCESSING
—Multiple-Dose Tirzepatide InjectionINJECTION, SOLUTION168 VIAL in 1 TRAY (43624-038-01) / .6 mL in 1 VIALDRUG FOR FURTHER PROCESSING
—tirzepatideINJECTION, SOLUTION168 VIAL, SINGLE-USE in 1 TRAY (43624-015-01) / .5 mL in 1 VIAL, SINGLE-USEDRUG FOR FURTHER PROCESSING
—tirzepatideINJECTION, SOLUTION168 VIAL, SINGLE-USE in 1 TRAY (43624-016-01) / .5 mL in 1 VIAL, SINGLE-USEDRUG FOR FURTHER PROCESSING
—tirzepatideINJECTION, SOLUTION168 VIAL, SINGLE-USE in 1 TRAY (43624-017-01) / .5 mL in 1 VIAL, SINGLE-USEDRUG FOR FURTHER PROCESSING
—tirzepatideINJECTION, SOLUTION168 VIAL, SINGLE-USE in 1 TRAY (43624-018-01) / .5 mL in 1 VIAL, SINGLE-USEDRUG FOR FURTHER PROCESSING
—tirzepatideINJECTION, SOLUTION168 VIAL, SINGLE-USE in 1 TRAY (43624-019-01) / .5 mL in 1 VIAL, SINGLE-USEDRUG FOR FURTHER PROCESSING
—tirzepatideINJECTION, SOLUTION168 VIAL, SINGLE-USE in 1 TRAY (43624-020-01) / .5 mL in 1 VIAL, SINGLE-USEDRUG FOR FURTHER PROCESSING

Source: FDA National Drug Code directory. A listing is a registration, not an FDA endorsement of the product.

Data sources · cited with retrieval dates

NADAC figures are pharmacy acquisition costs, not retail prices and not what you will pay. This content is educational and is not medical advice.